Home | Contact Us | FAQ | Search & Site Map | Link to Us
Sign In | Join | Other 45 Sites in Network
Home
Discussion Groups
General
GeneralCardiologyVisionDentistryPharmacyLaboratoryNutritionAlternative
Diseases and Disorders
AIDSAlzheimer'sArthritisAsthmaCancerBreast CancerDiabetesEpilepsyGlaucomaHepatitisHerpesLupusProstate BPHProstate CancerProstatitisSinusitisTinnitus

Medical Forum / Diseases and Disorders / Sinusitis / February 2008

Tip: Looking for answers? Try searching our database.

Long-term outcome analysis of endoscopic sinus surgery for chronic     sinusitis.

Thread view: 
Enable EMail Alerts  Start New Thread
Thread rating: 
truehawk - 09 Feb 2008 21:12 GMT
1: Am J Rhinol. 2007 Nov-Dec;21(6):743-7.Click here to read Links
   Long-term outcome analysis of endoscopic sinus surgery for chronic
sinusitis.
   Young J, Frenkiel S, Tewfik MA, Mouadeb DA.

   McGill University, Montreal, Quebec, Canada.
jonathan.young@mail.mcgill.ca

   BACKGROUND: The purpose of this study was to determine long-term
subjective outcome of endoscopic sinus surgery (ESS) for chronic
sinusitis (CS) and to evaluate prognostic indicators for surgical
treatment failure. METHODS: This is a prospective study of patients
who underwent ESS for CS. Symptom assessment was performed using a
visual analog scale at a pretreatment interview and then at regular
intervals post-ESS for up to a 3-year period. The indicators for
symptom scoring were nasal obstruction, facial pain, postnasal drip,
anterior discharge, and anosmia/hyposmia. RESULTS: Data analysis
indicates that ESS improves symptom scoring early on, but the effects
begin to dissipate over time. Anosmia/hyposmia is the most severe
symptom overall for all patient subgroups and recurs to a greater
degree 3 years postoperatively in Samter's Triad sufferers (p =
0.006), asthmatic patients (p = 0.002), and those with a worse CT scan
at presentation (p = 0.04). In addition, Triad sufferers who complain
of nasal obstruction and anterior nasal discharge have a significant
recurrence of their symptoms postoperatively (p = 0.04 and 0.001,
respectively). CONCLUSION: Individuals must be warned that ESS may not
be a long-term solution for CS because of its chronic nature. Patients
are relieved of their symptoms initially; however, these tend to recur
over a 3-year period. Samter's Triad is the strongest determinant of
long-term treatment failure. Asthma also is a determinant of treatment
failure, which lends credence to the notion of combined airway
disease. Allergy was not a strong determinant of treatment failure in
our study.
judy.n - 10 Feb 2008 14:16 GMT
> 1: Am J Rhinol. 2007 Nov-Dec;21(6):743-7.Click here to read Links
>     Long-term outcome analysis of endoscopic sinus surgery for chronic
[quoted text clipped - 29 lines]
> disease. Allergy was not a strong determinant of treatment failure in
> our study.

So, the 80% + efficacy of FESS doesn't hold. No surprise, it was never
clear exactly what criteria was used to define success.
Judy
truehawk - 10 Feb 2008 23:37 GMT
> > 1: Am J Rhinol. 2007 Nov-Dec;21(6):743-7.Click here to read Links
> >     Long-term outcome analysis of endoscopic sinus surgery for chronic
[quoted text clipped - 33 lines]
> clear exactly what criteria was used to define success.
> Judy

Hi Judy:

Yes the "criteria to determine success" is interesting.
However when I look at the results of this study I see a few other
things.
When I look at sinus anatomy on x-ray, I see a an air intake system of
fairly generous proportions. It take a LOT of layers of stuff to stop
it up.
To me it kind of validates my theory that once the gang is all there
it takes about 3 years for the biofilm to acrete  to the point where
it again causes constant drainage and obstructs breathing even if the
full compliment of species is already there.
That could also mean that many years passed between the initial bout
of flu that killed the cilia in the first place and the presentation
of chronic sinusitis.
Remember the thing about CT scans having a high number of "false
positives"? About 60% or more of people who had CT scans for other
reasons showed high density stuff in a thick blanket over at least
some of their sinuses.  Depending on the size of the nasal structures,
I think that sooner or later these people will "suddenly" realize that
they have sinusitis.

So cold steel can reduce the bug burden, but is not going to keep the
bugs from reclaiming the territory if something else is not done,
because there are little tubes running all over the place that the
surgeon can not scrape out will carry representatives from the whole
biofilm community that was there, and will allow the `film to
regrow.
We need vaccines against Staph, e-coli, and psudeo, and we need phages
that attack these bugs to get to the places where the immune system
can not go. Antibotics are wayyyyyyy better than nothing, but phages
seem to me to offer the best solution.

I wonder if you could ask some of your Russian colleges about the
incidence and treatment of sinusitis in Russia where phages are
evidently used with considerable success.
Michael - 25 Feb 2008 19:52 GMT
> > > 1: Am J Rhinol. 2007 Nov-Dec;21(6):743-7.Click here to read Links
> > >     Long-term outcome analysis of endoscopic sinus surgery for chronic
[quoted text clipped - 70 lines]
> incidence and treatment of sinusitis in Russia where phages are
> evidently used with considerable success.

The effect of bacterial biofilms on post-sinus surgical outcomes.
Psaltis AJ, Weitzel EK, Ha KR, Wormald PJ.
Department of Surgery-Otorhinolayrngology Head and Neck Surgery, The
University of Adelaide, Adelaide, South Australia.
Am J Rhinol. 2008 Jan-Feb;22(1):1-6.

BACKGROUND: Although the existence of biofilms on the sinus mucosa of
patients with chronic rhinosinusitis (CRS) is now well established,
the role that these structures play remains unclear. It is thought
that biofilms may contribute to the recalcitrant and persistent nature
that characterizes CRS, but little research exists documenting the
effect that they have on postoperative mucosal outcomes. This article
presents a retrospective analysis of sinus surgical patients and
correlates the presence of biofilms with mucosal outcomes. This study
was performed to evaluate the role that bacterial biofilms have on
post-sinus surgical outcomes. METHODS: A retrospective analysis of
prospectively collected data was performed on 40 patients undergoing
endoscopic sinus surgery (ESS) for CRS. Preoperative demographic,
clinical, and radiologic data were recorded from each patient and,
intraoperatively, sinus culture specimens and mucosal samples were
obtained for microbiological and microscopic examination. Biofilm
determination was performed using confocal scanning laser microscopy.
Postoperatively, patients were followed up for a minimum of 8 months
with endoscopic evaluation of their sinonasal mucosa. The presence of
ongoing symptoms was recorded also. RESULTS: Bacterial biofilms were
found in 20 (50%) of the 40 CRS patients. Patients with biofilms had
significantly worse preoperative radiological scores and,
postoperatively, had statistically worse postoperative symptoms and
mucosal outcomes. The only other factor that was statistically related
to an unfavorable outcome was the presence of fungus at the time of
surgery. In this study the presence of polyps, eosinophilic mucin, or
pus was not related to poor outcomes. CONCLUSION: This retrospective
study showed that bacterial biofilms and fungus were correlated with
the persistence of postoperative symptoms and mucosal inflammation
after sinus surgery for CRS. This provides evidence that biofilms
indeed may play an active role in perpetuating inflammation in CRS
patients and may explain the recurrent and resistant nature of this
disease. Therapies targeted at removing biofilms may be important in
the management of recalcitrant CRS

PMID: 18284851 [PubMed - in process]

Rate this thread:






 
Sign In
Join
My Latest Posts
My Monitored Threads
My Blog
My Photo Gallery
My Profile
My Homepage

Start New Thread
Enable EMail Alerts
Rate this Thread



©2008 Advenet LLC   Privacy Policy - Terms of Use
This website includes both content owned or controlled by Advenet as well as content owned or controlled by third parties.